Related Experiment Videos
[Current screening for molecular target therapy of cancer]
1Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, Japan.
Abstract:
Recent progress in molecular biology and cancer biology has revealed that many molecules, which are heavily involved in the un-limited growth, anti-apoptotic effects and invasion of tumors, would be targets of cancer therapy. Part of the drugs which inhibit these molecules have shown clinical response as well as clinical benefits. In this review article, the summary of mechanism based drug screening for cancer as well as recent status of new molecular target drugs for cancer, are described.
Insights
New cancer therapies target molecules driving tumor growth and spread. Some drugs inhibiting these molecular targets show promising clinical benefits in cancer patients.
Area of Science:
- Molecular biology
- Cancer biology
- Pharmacology
Background:
- Molecular and cancer biology advances identify key molecules in tumor growth, survival, and metastasis.
- These molecules represent potential targets for novel cancer therapies.
- Existing drugs targeting specific molecular pathways have demonstrated clinical efficacy.
Purpose of the Study:
- To review mechanism-based drug screening strategies for cancer.
- To summarize the current status of novel molecular target drugs in cancer therapy.
Main Methods:
- Literature review of recent advancements in molecular and cancer biology.
- Analysis of drug screening methodologies.
- Compilation of data on emerging molecular target drugs for cancer.
Main Results:
- Identification of critical molecular targets involved in unlimited cell growth, anti-apoptotic effects, and tumor invasion.
- Confirmation that drugs inhibiting these targets can yield clinical responses and benefits.
- Overview of current drug development pipelines for molecularly targeted cancer therapies.
Conclusions:
- Molecularly targeted therapies represent a significant advancement in cancer treatment.
- Mechanism-based drug screening is crucial for identifying effective cancer therapeutics.
- Continued research into molecular targets and drug development holds promise for improving patient outcomes.